Search Results 121-130 of 17123 for egfr

  1. Pulmonary Medicine Clinical Trials - Medical Professionals

    ... EGFR mutant population. Patients will be enrolled over a three year period across approximately 25 geographically diverse academic as well as community ...

  2. Mayo Clinic Minute: Research shows newer blood thinners have lower risk of kidney function decline

    People with A-fib often have problems with blood clots forming that can lead to strokes. To prevent the clots, health care providers generally prescribe these ...

  3. A Study of ASP8273 versus Erlotinib or Gefitinib as First-Line Treatment for Patients with Stage IIIB/IV Non-Small Cell Lung Cancer - Mayo Clinic

    ... (EGFR) activating mutations. This study will also assess overall survival, overall response rate, progression free survival assessed by the investigator ...

  4. A Study of Afatinib Treatment for Patients with Epidermal Growth Factor Receptor Mutation Positive Non-Small Cell Lung Cancer, Who Are Age 70 or Older - Mayo Clinic

    ... EGFR (epidermal growth factor receptor) mutations. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...

  5. Publications - Hussam Al Kateb, Ph.D. - Mayo Clinic

    EGFR transcript variants: Potential diagnostic biomarker for glioblastoma, IDH-wildtype? J Neuropathol Exp Neurol. 2025 Nov 1; 84 (11):1059-1062. View PubMed ...

  6. Uncovering the Signaling Events Underlying the Development and Progression of Pancreatic Cancer - Tumor Development, Immunology and Progression Laboratory - Mayo Clinic Research

    ... (EGFR). Dr. Storz and his research team hope to determine the roles of KRas- and NF-κB-induced signaling pathways in the development and progression of ...

  7. A Study of Heart and Kidney Protection with Empagliflozin - Mayo Clinic

    CKD-EPI eGFR ≥20 to <45 mL/min/1.73m² or ... Diabetes mellitus type 2 and prior atherosclerotic cardiovascular disease with an eGFR >60 mL/min/1.73m².

  8. Uncovering the Signaling Events Underlying the Development and Progression of Pancreatic Cancer - Tumor Development, Immunology and Progression Laboratory - Mayo Clinic Research

    ... (EGFR). Dr. Storz and his research team hope to determine the roles of KRas- and NF-κB-induced signaling pathways in the development and progression of ...

  9. Clinical trials - Urology

    ... (eGFR ≥ 60ml/min). Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies. Scottsdale/Phoenix, Ariz. The ...

  10. Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease - Mayo Clinic

    At present, we are enrolling participants with CKD, with a subset of participants with diabetic kidney disease (DKD), aged 40-80 years, and eGFR 15-60 mL/min/ ...